Showing results (331-340 of 2,504) with videos related to

Sort By:
Pageof 251
Endocrine-Related Cancer|October 4, 2008
Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entityM Capezzone, S Marchisotta, S Cantara, et al.
Endocrine-Related Cancer|October 1, 2008
Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantlyFulvia Daffara, Silvia De Francia, Giuseppe Reimondo, et al.
Endocrine-Related Cancer|October 1, 2008
ERBB2 influences the subcellular localization of the estrogen receptor in tamoxifen-resistant MCF-7 cells leading to the activation of AKT and RPS6KA2Sunil Pancholi, Anne E Lykkesfeldt, Caroline Hilmi, et al.
Endocrine-Related Cancer|October 2, 2008
Signaling pathways involved in the antiproliferative effect of molecular iodine in normal and tumoral breast cells: evidence that 6-iodolactone mediates apoptotic effectsO Arroyo-Helguera, E Rojas, G Delgado, et al.
Endocrine-Related Cancer|September 11, 2008
Medical therapy for clinically non-functioning pituitary adenomasAnnamaria Colao, Carolina Di Somma, Rosario Pivonello, et al.
Endocrine-Related Cancer|July 29, 2009
Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumoursD Alwyn Dart, Bradley Spencer-Dene, Simon C Gamble, et al.
Endocrine-Related Cancer|July 22, 2009
The association between serum TSH concentration and thyroid cancerKristien Boelaert
Endocrine-Related Cancer|July 18, 2009
Prostate cancer stromal cells and LNCaP cells coordinately activate the androgen receptor through synthesis of testosterone and dihydrotestosterone from dehydroepiandrosteroneAtsushi Mizokami, Eitetsu Koh, Kouji Izumi, et al.
Endocrine-Related Cancer|April 10, 2009
Progesterone receptors act as sensors for mitogenic protein kinases in breast cancer modelsGwen E Dressing, Christy R Hagan, Todd P Knutson, et al.
Endocrine-Related Cancer|November 14, 2008
Secretive and proliferative tumor profile helps to select the best imaging technique to identify postoperative persistent or relapsing medullary thyroid cancerA Faggiano, F Grimaldi, L Pezzullo, et al.
Pageof 251